Emmett Cunningham
CIK 1710382 · last filed 2023-06-16
Emmett Cunningham is a corporate insider who has filed 7 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for GRTX, was dated Jun 16, 2023.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
7
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Galera Therapeutics, Inc. (GRTX) Delisted | Director | — | $0.14 | — | $0 | 6 | 2023-06-16 |
| LUMOS PHARMA, INC. (LUMO) Delisted | Director | 709 | $4.34 | $3.1K | $0 | 1 | 2020-04-07 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-16 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-16 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-06 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-10 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-07 | LUMOS PHARMA, INC. (LUMO) Delisted | Grant (A) | +709 | $0 | EDGAR |
| 2019-11-08 | Galera Therapeutics, Inc. (GRTX) Delisted | Grant (A) | — | $0 | EDGAR |